- NLRC5 Functions beyond MHC I Regulation—What Do We Know So Far?
Szilvia Benkő et al, 2017, Front. Immunol. CrossRef - NLRC5/CITA: A Key Player in Cancer Immune Surveillance.
Sayuri Yoshihama et al, 2017, Trends Cancer CrossRef - High Expression of NLRC5 is associated with prognosis of gastric cancer
Yuemei Li et al, 2018 CrossRef - Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
Zheqi Zong et al, 2019, J Cell Mol Med CrossRef - null
Barbara Seliger et al, 2020 CrossRef - Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies
B. Seliger, 2016, HLA CrossRef - null
S.T. Chelbi et al, 2017 CrossRef - Emerging Roles for NLRC5 in Immune Diseases
Jie-quan Wang et al, 2019, Front. Pharmacol. CrossRef - NLRC5: new cancer buster?
Feng Tang et al, 2020, Mol Biol Rep CrossRef - Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
Daan P. Hurkmans et al, 2020, Cancer Immunol Immunother CrossRef - MHC class I transactivator NLRC5 in host immunity, cancer and beyond
Steven X. Cho et al, 2020, Immunology CrossRef - The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
Akhil Shukla et al, 2021, IJMS CrossRef - Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5‑FU chemotherapy by blocking the carcinogenic effect of YY1
Shan Liang et al, 2022, Exp Ther Med CrossRef - NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer
Yu Dong et al, 2022, Bioengineered CrossRef - NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
Madanraj Appiya Santharam et al, 2023, IJMS CrossRef - NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens
Galaxia M. Rodriguez et al, 2024, Front. Immunol. CrossRef